Keith Terada to Neoplasm Staging
This is a "connection" page, showing publications Keith Terada has written about Neoplasm Staging.
Connection Strength
0.337
-
Terada KY, Black M, Terada LH, Davis J, Shimizu DM. Survival of endometrial cancer patients with lymphatic invasion and deficient mismatch repair expression. Gynecol Oncol. 2013 Apr; 129(1):188-92.
Score: 0.104
-
Grzankowski KS, Shimizu DM, Kimata C, Black M, Terada KY. Clinical and pathologic features of young endometrial cancer patients with loss of mismatch repair expression. Gynecol Oncol. 2012 Sep; 126(3):408-12.
Score: 0.099
-
Terada K, Mattson D, Goo D, Shimizu D. DNA aneuploidy is associated with increased mortality for stage I endometrial cancer. Gynecol Oncol. 2004 Dec; 95(3):483-7.
Score: 0.059
-
Randall ME, Filiaci V, McMeekin DS, von Gruenigen V, Huang H, Yashar CM, Mannel RS, Kim JW, Salani R, DiSilvestro PA, Burke JJ, Rutherford T, Spirtos NM, Terada K, Anderson PR, Brewster WR, Small W, Aghajanian CA, Miller DS. Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer. J Clin Oncol. 2019 07 20; 37(21):1810-1818.
Score: 0.040
-
Clinton LK, Kondo J, Carney ME, Tauchi-Nishi P, Terada K, Shimizu D. Low-Volume Lymph Node Metastases in Endometrial Carcinoma. Int J Gynecol Cancer. 2017 07; 27(6):1165-1170.
Score: 0.035